Clinical trials
Active, not recruiting Phase 2 Overweight trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 9 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Pfizer | 2 |
| Shanghai Minwei Biotechnology Co., Ltd | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Beijing QL Biopharmaceutical Co.,Ltd | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Boehringer Ingelheim | 1 |
| Hoffmann-La Roche | 1 |
| Kailera | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 20 |
| Obesity | 19 |
| Body Weight | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Breast Neoplasms | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Diabetes Mellitus | 1 |
| Inflammation | 1 |
| Major Depressive Disorder | 1 |
| Nutrition Disorders | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.